Khaberni - Experts have said there is a new breath test specific to pancreatic cancer, which could cause a "breakthrough" in patient care, and the British news agency reported today, Wednesday, that there is currently an experiment underway to gauge the effectiveness of the world's first breath test for this disease, known for being difficult to detect in its early stages.
The "Pancreatic Cancer Organization" in the United Kingdom, which is funding the study, stated that launching the trial is "the most significant step towards achieving a breakthrough that could have saved lives since 50 years ago."
It is noted that the vague symptoms of the disease, which include back pain and indigestion, mean that the disease often goes undetected until it has spread to other parts of the body.
A recent review of pancreatic cancer in England and Wales revealed that most pancreatic cancer patients are diagnosed at a late stage - with 62% of patients in England and 65% of patients in Wales being diagnosed in stage four.
It is noted that survival rates for this type of cancer are particularly low, with approximately 22% of those diagnosed in England not surviving for 30 days after their diagnosis, compared to 21% in Wales.
